535961-78-5Relevant articles and documents
SYNTHESIS OF CRAC CHANNEL INHIBITORS
-
Paragraph 0184, (2020/11/23)
A convergent synthetic method for the production of CRAC channel inhibitors is described herein. The synthetic method provides a method for producing highly pure CRAC channel inhibitors for clinical testing.
SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE
-
Paragraph 374, (2016/10/04)
The invention relates to the preparation and use of new aminopyrimidine derivatives as drug candidates in free form or in pharmaceutically acceptable salt form and formulations thereof for the modulation of a disorder or disease which is mediated by the activity of the PI3K enzymes. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of disorders or diseases, such as disorders of immunity and inflammation in which PI3K enzymes play a role in leukocyte function, and hyperproliferative disorders associated with PI3K activity, including but not restricted to leukemias and solid tumors, in mammals, especially humans.
C5aR ANTAGONISTS
-
Page/Page column 18, (2010/07/04)
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a recepto